Home › Compare › MYCOF vs STAG

MYCOF vs STAG: Dividend Comparison 2026

MYCOF yields 151.75% · STAG yields 3.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MYCOF wins by $26.48M in total portfolio value
10 years
MYCOF
MYCOF
● Live price
151.75%
Share price
$1.32
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.50M
Annual income
$11,538,455.63
Full MYCOF calculator →
STAG
STAG Industrial Inc.
● Live price
3.44%
Share price
$36.06
Annual div
$1.24
5Y div CAGR
0.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18.3K
Annual income
$462.70
Full STAG calculator →

Portfolio growth — MYCOF vs STAG

📍 MYCOF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMYCOFSTAG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MYCOF + STAG cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
MYCOF pays
STAG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MYCOF
Annual income on $10K today (after 15% tax)
$12,898.33/yr
After 10yr DRIP, annual income (after tax)
$9,807,687.29/yr
STAG
Annual income on $10K today (after 15% tax)
$292.69/yr
After 10yr DRIP, annual income (after tax)
$393.29/yr
At 15% tax rate, MYCOF beats the other by $9,807,293.99/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MYCOF + STAG for your $10,000?

MYCOF: 50%STAG: 50%
100% STAG50/50100% MYCOF
Portfolio after 10yr
$13.26M
Annual income
$5,769,459.17/yr
Blended yield
43.52%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on STAG right now

MYCOF
No analyst data
Altman Z
-4888.6
Piotroski
3/9
STAG
Analyst Ratings
9
Buy
9
Hold
3
Sell
Consensus: Buy
Price Target
$45.00
+24.8% upside vs current
Range: $39.00 — $59.00
Altman Z
1.2
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MYCOF buys
0
STAG buys
0
No recent congressional trades found for MYCOF or STAG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMYCOFSTAG
Forward yield151.75% ✓3.44%
Annual dividend / share$2.00 ✓$1.24
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0.3% ✓
Portfolio after 10y$26.50M ✓$18.3K
Annual income after 10y$11,538,455.63 ✓$462.70
Total dividends collected$24.54M ✓$4.0K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: MYCOF vs STAG ($10,000, DRIP)

YearMYCOF PortfolioMYCOF Income/yrSTAG PortfolioSTAG Income/yrGap
1← crossover$25,875$15,174.51$10,665$345.38+$15.2K → MYCOF
2$64,380$36,694.66$11,365$358.01+$53.0K → MYCOF
3$154,217$85,329.77$12,099$370.76+$142.1K → MYCOF
4$356,039$191,027.06$12,870$383.63+$343.2K → MYCOF
5$793,132$412,170.66$13,678$396.60+$779.5K → MYCOF
6$1,706,759$858,106.90$14,526$409.67+$1.69M → MYCOF
7$3,552,006$1,725,774.37$15,413$422.82+$3.54M → MYCOF
8$7,157,264$3,356,617.38$16,343$436.05+$7.14M → MYCOF
9$13,979,354$6,321,081.53$17,315$449.35+$13.96M → MYCOF
10$26,496,364$11,538,455.63$18,332$462.70+$26.48M → MYCOF

MYCOF vs STAG: Complete Analysis 2026

MYCOF — Stock

Noveris Health Sciences Inc. is a biotechnology company, which engages in the research, drug development, and clinical trials of psilocybin products. The company was founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013 and is headquartered in Vancouver, Canada.

Full MYCOF Calculator →

STAG — REIT

STAG Industrial, Inc. (NYSE: STAG) is a real estate investment trust focused on the acquisition and operation of single-tenant, industrial properties throughout the United States. By targeting this type of property, STAG has developed an investment strategy that helps investors find a powerful balance of income plus growth.

Full STAG Calculator →
📬

Get this MYCOF vs STAG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MYCOF vs SCHDMYCOF vs JEPIMYCOF vs OMYCOF vs KOMYCOF vs MAINMYCOF vs PLDMYCOF vs EQRMYCOF vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.